Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People With Diabetes: 10-11 February 1998, Miami, Florida

Diabetes Care

Volumn 21, Issue 9, 1998, Pages 1551-1559

  Kahn, Richard ^a  

^a AMERICAN DIABETES ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ARTERY DISEASE; ATHEROSCLEROTIC PLAQUE; AUTONOMIC INNERVATION; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE DURATION; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; EXERCISE TEST; FOLLOW UP; HEART PROTECTION; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; REVASCULARIZATION; REVIEW; THROMBOGENESIS;

EID: 0031752129     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.9.1551     Document Type: Review

References (20)

1. Pyörälä K, Pedersen TR, Kjeksus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disaese: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
2. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L. Warnica JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001-1009, 1996
3. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
4. American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 21, (Suppl. 1):S36-S39, 1998
5. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2445, 1997
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
7. Malmberg K, Ryden L, Eferdic S, Herlitz J, Nicol P, Waldenstram A, Wedel H: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26:57-65, 1995
8. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:71-72, 81-106, 1994
9. ETDRS Investigators: Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268:1292-1300, 1992
10. Steering Committee of the Physicians' Health Study Research Group: Final report of the aspirin component on the ongoing Physicians' Health Study. N Engl J Med 321:129-135, 1989
11. American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 20:1772-1773, 1997
12. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 21 (Suppl. 1):S23-S31, 1998
13. Jonas M, Reicher-Reiss H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, Bahar S: Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Am J Cardiol 77:1273-1277, 1996
14. The Bypass Angioplasty Revascularization lnvestigation/(BARI) Investigators: Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multi-vessel disease. Circulation 96:1761-1769, 1997
15. Van Belle E, Bauters C, Hubert E, Bodart J-C, Abolmaali K, Meurice T, McFadden EP, Lablanche J-M, Bertrand ME: Retenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96: 1454-1460, 1997
16. Criqui MH, Langer RD, Fronek A, Feigeison HS, Klauber MR, McCann TJ, Browner D: Mortality over 10 years in patients with peripheral arterial disease. N Engl J Med 326:381-386, 1992
17. Dinneen SF, Gerstein HC: The association of mircoalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Int Med 157:1413-1418, 1997
18. Caracciolo E, Chaitman BR, Forman SA, Stone PH, Bourassa MG, Sopko G, Geller NL, Conti CR: Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients: an ACIP database study Circulation 93:2097-2105, 1996
19. Gerson MC, Khoury JC, Hertzberg VS, Fischer EE, Scott RC: Prediction of coronary artery disease in a population of insulin-requiring diabetic patients: results of an 8-year follow-up study Am Heart J 116:820-826, 1988
20. Wong JB, Sommenberg FA, Salem DN, Pauker SG: Myocardial revascularization for chronic stable angina: an analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 113:852-871, 1990